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Antibody-independent identiﬁcation of bovine
milk-derived peptides in breast-milk
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Exclusively breast-fed infants can exhibit clear signs of IgE or non IgE-mediated cow’s milk allergy.
However, the deﬁnite characterization of dietary cow’s milk proteins (CMP) that survive the maternal
digestive tract to be absorbed into the bloodstream and secreted into breast milk remains missing. Herein,
we aimed at assessing possible CMP-derived peptides in breast milk. Using high performance liquid
chromatography (HPLC)-high resolution mass spectrometry (MS), we compared the peptide fraction of
breast milk from 12 donors, among which 6 drank a cup of milk daily and 6 were on a strict dairy-free
diet. We identiﬁed two bovine β-lactoglobulin (β-Lg, 2 out 6 samples) and one αs1-casein (1 out
6 samples) fragments in breast milk from mothers receiving a cup of bovine milk daily. These CMP-
derived fragments, namely β-Lg (f42–54), (f42–57) and αs1-casein (f180–197), were absent in milk from
mothers on dairy-free diet. In contrast, neither intact nor hydrolyzed β-Lg was detected by western blot
and competitive ELISA in any breast milk sample. Eight additional bovine milk-derived peptides identiﬁed
by software-assisted MS were most likely false positive. The results of this study demonstrate that
CMP-derived peptides rather than intact CMP may sensitize or elicit allergic responses in the neonate
through mother’s milk. Immunologically active peptides from the maternal diet could be involved in
priming the newborn’s immune system, driving a tolerogenic response.
Introduction
Cow’s milk proteins (CMP) derived from maternal diet can
elicit IgE- or non IgE-mediated allergic response in exclusively
breastfed infants.1,2 In spite of clinical evidence, definite proof
on a molecular basis that CMP flow into breast milk remains
missing.
In addition to the potential primary (direct) and secondary
(indirect) involvement in inducing adverse reactions in a
selected cohort of allergic newborns, the exposure to allergens
through breast milk has relevant physiological implications, as
these allergens might be involved in priming the newborn’s
immune system to tolerate harmless food and foreign
proteins.3
The passage of low amounts of food-derived allergens into
breast milk as a possible route of sensitization has been
suggested.4–7 Using immunochemical assays, Vadas et al.
detected Ara h 1 and Ara h 2 allergens in breast milk of lactat-
ing women who had consumed roasted peanuts.8 More
recently, other authors identified a diﬀerent peanut allergen in
breast milk, i.e. Ara h 6, less than ten minutes after peanut
ingestion.9 A direct correlation has been described between
the dose of egg intake and the amount of intact ovalbumin in
breast milk.10 On the contrary, wheat intake and levels of non-
degraded gliadins in blood serum or breast milk are not corre-
lated.11 Breast milk has been described to contain a basal level
of immunoreactive gliadins even before intake of wheat,
suggesting a certain degree of cross-reactivity between anti-
gliadin antibodies and endogenous human milk proteins, pro-
vided that the mothers strictly complied with the avoidance
diet during trial.12 Thus, in general the definition of the
immunological determinants at this stage appears quite
controversial, mainly due to the lack of validation of the
immunochemical methods of detection, which can be biased
by cross-reactivity or nonspecific antibody recognition.13,14
Whether β-lactoglobulin (β-Lg) occurs in human milk has
been debated for many years. The scientific community now
commonly accepts that humans do not express β-Lg. However,
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variable amounts of β-Lg have been detected in human milk by
immunochemical techniques, supposedly being bovine β-Lg of
dietary origin.15 β-Lg is highly resistant to pepsin, the main
gastric protease, while it is extensively degraded by pancreatic
proteases, before possible absorption in the small intestine.16
In contrast, caseins are quickly proteolyzed under both gastric
and intestinal conditions.17 Interestingly, authors who had pre-
viously attributed the detection of β-Lg to antibody nonspecific
recognition18,19 have later described intact bovine αs1-casein in
human milk20 and colostrum.21 Although the identification of
αs1-casein was based on mass spectrometry (MS)-based prot-
eomics, these findings seem to conflict with the prompt diges-
tion of caseins in the gastro-intestinal tract of the lactating
mother. Indeed, the likelihood that CMP-derived peptides are
transferred into milk through the mammary epithelium is
much higher than for intact parent proteins. Nevertheless, no
published research has attempted to detect immunologically
active fragments of food allergens in human breast milk.
The aim of the current study was to assess the occurrence
of CMP-derived peptides in breast milk using an antibody-
independent method, such as high performance liquid chrom-
atography (HPLC) coupled with high-resolution MS. Via
HPLC-MS, the peptide fractions of mature (after colostrum-to
milk transition) breast milk samples from mothers regularly
consuming bovine milk and other dairy products were com-
pared to those from mothers on a strict dairy-free diet.
Materials and methods
Samples of mature breast milk (40 mL) were obtained through
a breast pump equipped with plastic disposable pump sets
from 12 non-atopic healthy donors (median age: 32 years old)
who delivered at term, 2–4 weeks after parturition. All subjects
were from across the Campania region in Italy. A written
informed consent was provided by the mothers before the
milk collection.
Six of the samples were collected from women who drank
one cup of pasteurized bovine milk daily and regularly con-
sumed other dairy products. Six control samples were collected
from women on a strict milk- and dairy product-free diet since
at least one week, opportunely instructed to avoid any possible
sources of CMP. Breast milk of milk-drinking mothers was col-
lected 2 hours after a regular milk load (200 mL). A skilled
operator at the Department of Translational Medicine of the
University of Naples “Federico II” (Italy) supervised the admin-
istration of bovine milk, sample collection and code labelling.
Within less than 3 min after milk expression, the operator
added a serine-protease inhibitor (Pefabloc®, Sigma, St Louis,
MI, USA) to each sample (1 mM final concentration) and
immediately froze the samples of milk at −20 °C. High purity
grade solvents and chemicals were from Sigma.
Peptide extraction
Aliquots of each milk sample were skimmed by centrifugation
(3000g for 15 min at 4 °C) and the upper fat layer was removed
with a spatula (repeated twice). Proteins of skimmed milk were
precipitated (at 4 °C) with 12% (w/v) trichloroacetic acid (TCA)
final concentration and soluble peptides were solid-phase
extracted using Sep-Pak C18 pre-packed columns (Waters,
Milford, USA). After loading, peptides were extensively washed
with 0.1% trifluoroacetic acid (TFA) and eluted with 70%
acetonitrile containing 0.1% TFA. The organic solvent was
evaporated in a vacuum centrifuge (SpeedVac, Savant) and
peptides were finally lyophilized.
Competitive ELISA for β-Lg fragments
The presence of β-Lg-derived peptides in the breast milk
samples was assayed using the RIDASCREEN® competitive
ELISA kit, specifically developed for the detection of hydro-
lyzed fragments of β-Lg (R4901, R-Biopharm AG, Darmstadt,
Germany). The assay was carried out according to the manu-
facturer’s instruction, using intact bovine β-Lg as a standard.
The samples were assayed in triplicate. Standard points fit a
cubic spline curve that was built using the Ridasoft Win soft-
ware vers. 1.91 (R-Biopharm AG). Breast milk was assayed at
several dilutions, including 1/500 (recommended by the manu-
facturer), 1/200, 1/100, and 1/50 (v/v). To exclude matrix
eﬀects, control breast milk samples spiked with variable
amounts of β-Lg were used as the positive control. The manu-
facturer’s declared limit of detection and limit of quantifi-
cation were 0.115 ppm and 5 ppm, respectively, with
<1% cross-reactivity with caseins or other whey proteins.
Western blotting detection of intact β-Lg
The 12% TCA insoluble breast milk proteins were three-fold
washed with diethyl ether and assayed for intact β-Lg by
western blot analysis. The proteins were dissolved in Laemmli
sample buﬀer at 1 mg mL−1 and 10 µg were separated by
SDS-PAGE using 12% acrylamide precast gels (Bio-Rad Labora-
tories, Hercules, CA, USA). Gels were run in duplicate; after
separation, one gel was stained using G-250 Coomassie Blue
Silver staining while the other was electroblotted onto nitro-
cellulose membranes using a Trans-Blot Cell (BioRad) at
400 mA at 4 °C for 1 h. The membranes were blocked for 1 h at
room temperature with 5% (w/v) bovine serum albumin
(Sigma) in a Tris-buﬀered saline solution with 0.05% Tween 20
(TBS-T) and incubated overnight at 4 °C, with immunoaﬃnity
purified anti-β-Lg IgG polyclonal antibody developed in rabbit
(Abcam Ltd, Cambridge, UK) previously diluted 1/10 000 in
TBS-T. Monoclonal peroxidase-conjugated mouse anti-rabbit
IgG antibody (Sigma) diluted in TBS-T (1/10 000) was applied
to the membrane for 1 h at room temperature. The membrane
was extensively rinsed with TBS-T (3 × 10 min) and finally with
TBS (1 × 10 min) before development. Chemiluminescence
reagents (ECL Plus WB reagent, GE Healthcare) and X-ray film
(Kodak, Chalons/Saône, France) were used to visualize the
immunoreactive protein bands at various exposure times
ranging from 0.5 to 5 min. A sample of bovine whey was used
as the positive control. The positive control contained 2 µg or
1–100 pg of β-Lg for the SDS-PAGE and western blot analyses,
respectively.
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HPLC separation was performed on a Waters NanoAcquity
UHPLC (Waters Corporation) with a Proxeon nanospray
source. The digested peptides were reconstituted in 3% aceto-
nitrile/0.1% formic acid and roughly 3 µg of each sample was
loaded onto a 100 µm × 25 mm Magic C18 100 Å 5U reverse
phase trap, where they were desalted online before being sep-
arated on a 75 micron × 150 mm Magic C18 200 Å 3U reverse
phase column. Peptides were eluted using a gradient of 0.1%
formic acid (A) and 100% acetonitrile (B) with a flow rate of
300 nL min−1. A 60 min gradient was run with 5% to 35% B
over 50 min, 35% to 80% B over 3 min, 80% B for 1 min, 80%
to 5% B over 1 min, and finally held at 5% B for 5 minutes.
Each sample run was followed by a 60 min column wash. Mass
spectra were collected on a Q Exactive Plus hybrid quadrupole-
Orbitrap mass spectrometer (Thermo Fisher Scientific) in a
data-dependent mode with one MS precursor scan followed by
15 MS/MS scans. A dynamic exclusion of 20 s was used. MS
spectra were acquired with a resolution of 70 000 and a target
of 1 × 106 ions or a maximum injection time of 30 ms. MS/MS
spectra were acquired with a resolution of 17 500 and a target
of 5 × 104 ions or a maximum injection time of 50 ms. Peptide
fragmentation was performed using high-energy collision dis-
sociation with a normalized collision energy value of 27. Un-
assigned charge states as well as ions >+6 were excluded from
MS/MS fragmentation.
Database search and peptide identification
LC-MS/MS raw data was converted to .mgf format and analyzed
by the oﬄine search engine X!Tandem22 as described pre-
viously,23 with some modifications. Briefly, mass spectral data
were searched against the bovine proteome (downloaded from
uniprot.org) to identify naturally-occurring peptides which
could have originated from a bovine protein. An error toler-
ance of 10 and 20 ppm was specified for precursor and frag-
ment m/z values, respectively. A minimum e value of 0.01 was
required of all peptide matches, corresponding to a 99% confi-
dence score. Oxidation of methionine was allowed as a poten-
tial modification, and phosphorylations of serine and
threonine were allowed as potential modifications in a single
refinement step. The output of the software was refined to
exclude peptides which could have originated from a human
protein. Since there is a significant overlap between human
and bovine milk protein sequences, it was necessary to refine
the data further by identifying peptides that matched both pro-
teomes. The output of the software was entered into the
Uniprot BLAST search engine (uniprot.org/blast) and searched
against mammalian proteomes, with a maximum allowable
e value of 10. Peptides that were an exact match to a human
sequence under these conditions were removed from the final
results list. Next, a list of bovine milk proteins was assembled
from prior proteomic studies.24–26 Peptides not originating
from one of these proteins were also excluded from the final
results.
To further characterize the samples and assess the perform-
ance of the peptide extraction, mass spectral data were also
searched for naturally-occurring human milk peptides.
The search employed the same parameters used to identify
bovine milk-derived peptides and referenced a library of
proteins previously identified in proteomic studies of human
milk.27–30
3D molecular modelling
The molecular structure prediction of β-Lg was carried out
using the on-line resource I-TASSER (http://zhanglab.ccmb.
med.umich.edu/I-TASSER/), provided by the Department of
Computational Medicine and Bioinformatics, University of
Michigan, USA.
Results and discussion
LC-high resolution tandem mass spectrometry
Human milk is intrinsically rich in oligopeptides31 which are
released from milk proteins by endogenous proteases.32,33
These peptides are present at an even higher amount in pre-
term than in term breast milk.34 The tandem MS-based identi-
fication of foreign peptides (if any) occurring at trace levels in
breast milk challenges the dynamic range of MS alone. There-
fore, prior to MS analysis, peptides must be separated with
high resolution chromatography. Although the identification
of possible bovine milk-derived peptides is restricted to a rela-
tively low number of abundant proteins (casein and major
whey proteins), it requires an untargeted approach, due to the
lack of any predictable specificity of protein cleavage. The com-
plexity of such a combination of “deep” and “untargeted” pep-
tidomics is probably the reason why food allergen-derived
peptides have not been detected in human milk so far.
In the current case, the identification of bovine milk-
derived peptides in breast milk could be further complicated
by the homology among the corresponding milk specific pro-
teins. However, the most abundant protein components of
human milk, β-casein, αs1-casein and α-lactalbumin share 53,
31 and 74% homology, respectively, with their bovine counter-
parts, thereby oﬀering a fair margin to discriminate peptides
according to their origin. As the intent of the research is to
identify peptides unique to bovine milk occurring in human
milk (that may induce sensitization or allergic reaction to
bovine milk), peptides completely homologous between the
two species were irrelevant to our search.
On average, each sample of milk contained more than 1100
endogenous human milk protein-origin peptides (e ≤ 0.01).
These human milk peptides were derived from mostly
β-casein, osteopontin, and toll-like receptor 9. Overall, 11 pep-
tides were identified as matching bovine milk protein-derived
peptides, while they did not match protein sequences of
human milk (Table 1). All raw data and X!Tandem peptide
results are available in the ProteomeXchange database with
identifier PXD003657.
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The most significant finding was the identification of a
αs1-casein fragment and two peptides from β-Lg in the milk of
lactating mothers who drank bovine milk. These peptides were
not detected in any control samples. In relation to the β-Lg-
derived peptides, one breast milk sample contained β-Lg
(f42–54) and β-Lg (f42–57), while an additional sample con-
tained only β-Lg (f42–54). The αs1-casein (f180–197) was found
in an independent sample and it probably survived digestion,
because it belongs to a relatively proteolysis-resistant region of
the protein.35 No additional casein peptides were detected,
most likely due to their prompt and extensive degradation by
the gastro-intestinal system of the mother. The MS/MS spec-
trum of β-Lg (f42–57) is shown in Fig. 1 with the assignment
of the most intense fragments, also manually validated.
Notably, this spectrum did not match any protein sequence in
the human database. After identification, the CMP-derived
peptides were also searched in the remaining samples using a
targeted approach (peptide ion extraction) unsuccessfully.
The most frequently identified bovine milk protein peptides
were those from osteopontin, a well-described milk protein,
which also occurs in human milk.29,36 The peptide derived
from bovine osteopontin has a closely related sequence in
human osteopontin (GLK̲SR ̲SKKF in bovine versus GLR̲SK̲SKKF
in human), exhibiting the same molecular weight and
diﬀering only because of a positional K/R inversion. Hydrolytic
events also release a significantly high number of osteopontin
peptides in human milk.34 A manual inspection of the spectra
confirmed that the lack of the fragmentation ions at the level
of the K or R residues resulted in a software mismatch, thereby
justifying the identification of this peptide as of bovine origin
rather than human and its detection even in the control
samples (milk from mothers on milk-free diet). Toll-like recep-
tor 9 is a very minor protein of milk and it seems quite
improbable that some specific domains could survive maternal
digestion and flow into breast milk at a relatively high amount.
Indeed, a peptide from Toll-like receptor 9 was also detected in
a control sample. The peptides from xanthine dehydrogenase
and lactoferrin (1 peptide each) identified in samples from
milk-drinking mothers are probable candidate fragments of
bovine origin. However, the confidence of their identification
was low because they both contain free C residues, which
under not-reducing conditions are expected to be engaged in
disulfide bonds. A similar observation might hold for a
peptide from bile salt-activated lipase, which contains two
C residues and was identified in one control sample. The
bovine and human sequences of bile salt-activated lipase in
that region only diﬀer by an N(bovine) → D(human) substi-
tution inducing a shift of 1 mass unit besides an isobaric L→ I.
For the reasons above, the peptides from minor milk proteins,
diﬀerently from those from β-Lg and αs1-casein, are most likely
false positive identifications, thereby emphasizing that soft-
ware-assisted characterization should be carefully and critically
evaluated. In the current case, the presence or absence of
these peptides has only technical relevance, because they
should not be involved in immunological mechanisms.
Competitive ELISA for β-Lg fragments
A competitive ELISA was applied to detect β-Lg peptides in
breast milk samples. The ELISA kit is specifically designed to
detect peptides arising from processed β-Lg in food matrices.















GLKSRSKKF Osteopontin (159–167) P31096 5 1 4
YGLKSRSKKF Osteopontin (158–167) P31096 1 — 1
VAPGALLGLGNLTHLSLKYNNLTEVPRRLPPSLDTL Toll-like receptor 9 (189–224) Q5I2M5 3 1 2
VAPGALLGLGNLTHLSLKYNNLTEVPRRLPPSLDT Toll-like receptor 9 (189–223) Q5I2M5 1 — 1
YVEELKPTPEGDL β-Lactoglobulin (42–54) P02754 2 — 2
YVEELKPTPEGDLEIL β-Lactoglobulin (42–57) P02754 1 — 1
RCLQATLTQDSTYGNEDCLYLNIWVPQGR Bile salt-activated lipase (81–109) P30122 1 1 —
SDIPNPIGSENSEKTTM*PLW αs1-Casein (180–197) P02662 1 — 1
ASVAVEPQLSVVTRVANLPLVS Perilipin-2 (2–23) Q9TUM6 1 1 —
AKDTVTCVGHIIGA Xanthine dehydrogenase/oxidase
(656–669)
P80457 1 — 1
YPNLCQLCKGEGENQ Lactotransferrin (185–199) P24627 1 — 1
Fig. 1 Identiﬁcation of β-Lg (f42–54) through the MS/MS spectrum of
the peptide precursor [M + 2H]2+ = 745.37. The most intense y- and b-/
a-fragments are assigned.
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Standard β-Lg solutions fit a cubic spline curve. Only one
sample gave a positive response, with an apparent β-Lg concen-
tration of 2.1 ppm; however, this concentration was below the
limit of quantification of the assay (5 ppm). The ELISA β-Lg-
positive sample was a control and therefore the presence of
β-Lg peptides should be ruled out. In all the remaining
samples, assayed at varying sample dilutions, β-Lg peptides
were undetectable, at a 0.115 ppm limit of detection. The
inconsistency of the ELISA results demonstrates that immuno-
logical methods suﬀer from bias, most likely due to the speci-
ficity of the antibody reactivity. The pitfalls of the ELISA-based
methods in the detection and quantification of allergens in
complex food matrices have been recently reviewed.14
Western blotting detection of intact β-Lg
The SDS-PAGE and parallel western blot analyses of the breast
milk samples are shown in Fig. 2. Bovine whey proteins were
used in both cases as a positive control for β-Lg. Estimated
amounts of β-Lg were 2 µg for the SDS-PAGE analysis and
1–100 pg for the ECL reagent based detection, respectively.
The estimated limit of detection of β-Lg by the western blot
was well below 0.1 ppm (1 pg with respect to 10 µg total
protein). β-Lg was clearly detected in the whey protein extract
with both the analyses, while no band ascribable to it was
detected in any of the breast milk samples. These results con-
firmed the absence of intact bovine β-Lg or derived large
immunoreactive fragments at detectable amounts.
Significance of the presence of bovine milk derived peptides in
breast milk
β-Lg and αs1-casein are major allergens of bovine milk.37 For
the first time, fragments released from allergenic proteins
have been identified in human milk. The detection of aller-
gen-derived peptides in breast milk opens a new perspective to
monitor potential oﬀending components arising from the
maternal diet. Milk proteins are extensively processed along
the gastro-intestinal tract of the mother, before intestinal
absorption and systemic distribution. Although caseins are
more abundant than whey proteins in bovine milk (roughly
80 : 20 w/w), they undergo a very early degradation in the
stomach and then further in the intestine.17
In contrast, β-Lg is highly resistant to gastric pepsin diges-
tion and large peptides derived from it could escape duodenal
degradation. The β-Lg (f42–54) and β-Lg (f42–57) peptides
belong to a two β-sheet domain that is located in the lipid
binding calix of the native protein (Fig. 3). In milk, β-Lg is most
likely complexed with some small hydrophobic ligands, such as
fatty acids or retinoids that could limit the access of proteases
to the sensitive bonds. As assessed with I-TASSER simulations,
β-Lg conformation should not considerably vary between free
and fatty acid-complexed forms. The tertiary structure is also
stable at the gastric acidic pH.38 Thus, even in the non-com-
plexed protein the calix is buried inside the hydrophobic core of
the protein and should be spared by proteolysis at least in part.
Fig. 2 SDS-PAGE electrophoresis (A) and anti-β-Lg western blotting (B) of the 12 samples of human milk analyzed. Bovine whey proteins (bWP)
were loaded as the β-Lg positive control. For the western blotting analysis, the estimated amount of β-Lg in bWP control was 10 and 1 pg (upper
panel) and 100 and 50 pg (lower panel).
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To this purpose, the peptides of the region 40–60 of β-Lg are
relatively resistant to the simulated gastric-duodenal-intestinal
digestion of milk proteins, also including peptidases from
Caco-2 cells39 and the jejunal brush border membrane.35 The
high local number of acidic residues could also explain the
resistance of this protein domain to digestion.17
Through breast milk, peptides from maternal diet can
induce early and occult sensitization to food. Alternatively, the
early exposure to low amounts of immunogenic epitopes could
result in tolerogenic and protective responses.40,41 The immuno-
logical mechanisms that might underlie these events are still
unclear, further complicated by the variability in the frequency
and concentration of foreign peptides/proteins in breast milk.
Indeed, in our study β-Lg peptides were detected only in two
milk samples, thus confirming that the kinetics of dietary com-
ponents is aﬀected by high individual variability,15 most likely
depending on varying gastro-intestinal digestion capacity or
intestinal permeability as well as integrity of the mammary
tissue. The secretion of β-Lg peptides into breast milk could
also be related to long-term consumption of cow’s milk, as
higher levels of the protein have been reported in the milk of
subjects who are used to consuming milk in large amounts.42
Conclusions
Immunologically active peptides derived from CMP in the
maternal diet, rather than intact allergens, could be respon-
sible of adverse responses in exclusively breast-fed newborns.
These findings also indirectly prove that dietary protein frag-
ments, albeit in low amounts, can survive gastro-intestinal
digestion to be absorbed into the bloodstream and distributed
to peripheral organs. Data herein are in line with the very
recent detection of gluten-derived immunogenic peptides in
the urine of celiac subjects.43
We did not accurately quantify the β-Lg peptides in breast
milk samples. However, we can infer from the MS spectral
count that they occur at a very low relative abundance.
Whether trace amounts of these peptides are able to sensitize
and elicit allergic responses or contribute to priming the
immune system, promoting the acquisition of the oral toler-
ance, remains unknown. From this perspective, the time
course of dietary peptide appearance in breast milk and the
minimum amount of a dietary protein inducing a detectable
presence of peptides in breast milk are important next steps
for this research. In consideration of the very low amounts
(if any) of potentially immunogenic protein fragments in
breast milk, our data support the current guidelines according
to which maternal elimination diets during pregnancy and lac-
tation are not recommended as a strategy to prevent childhood
allergies of ‘at risk’ infants.7,44
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Fig. 3 3D structure of non-complexed β-Lg. The β-Lg 42–57 domain is highlighted in the unrolled model (left panel) and indicated in the X-ray
crystal structure of monomer β-Lg (middle panel, PDB data bank). The molecular structure prediction (right panel) performed with I-TASSER
conﬁrms that β-Lg 42–57 belongs to the lipid binding calix of the protein.
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